#marketfacts #stockmarket #BEAM #americanstock #americanreport

Beam Therapeutics Inc. (NASDAQ: BEAM): Precision genetic medicine innovator, strong buy

Beam Therapeutics Inc. (NASDAQ: BEAM) is a pioneering biotechnology company headquartered in Cambridge, MA, at the forefront of precision genetic medicine. Founded in 2017 by esteemed scientists David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung,…

Similar Posts